期刊
ANNALS OF NEUROLOGY
卷 64, 期 3, 页码 348-352出版社
WILEY-BLACKWELL
DOI: 10.1002/ana.21446
关键词
-
资金
- MRC [G0701075] Funding Source: UKRI
- Medical Research Council [G0701075] Funding Source: researchfish
- Intramural NIH HHS [Z99 AG999999] Funding Source: Medline
- Medical Research Council [G0701075] Funding Source: Medline
- Parkinson's UK [G-0907] Funding Source: Medline
We analyzed whether genetic variation of alpha-synuclein modulates the extent of neuropathological changes in a population-based autopsied sample of 272 elderly Finns. None of the 11 markers was associated with the extent of neocortical P-amyloid pathology. The intron 4 marker rs2572324 was associated with the extent of neurofibrillary pathology (p = 0.0006, permuted p = 0.004; Braak stages IV-VI vs 0-II). The same variant also showed a trend for association with neocortical Lewy-related pathology. These results suggest for the first time that variation of alpha-synuclein modulates neurofibrillary tau pathology and support the recent observations of an interaction of alpha-synuclein and tau in neurodegeneration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据